BiotechTube
Home/NanoMedSyn/Marcel Garcia
MG

Marcel Garcia

CEO

NanoMedSyn

Therapeutic Areas

Metabolic DisordersOncologyImmunologyInflammation

NanoMedSyn Pipeline

DrugIndicationPhase
AMFA-Enzyme Conjugate (Pompe Disease)Pompe Disease (Lysosomal Storage Disorder)Pre-clinical

Leadership Team at NanoMedSyn

AM
Alain Morère
Co-founder, Scientific Advisor
JD
Jean-Olivier Durand
Co-founder, Scientific Advisor
MG
Magali Gary-Bobo
Co-founder, Scientific Advisor
View full NanoMedSyn profile